Byline: Bill Lucas, Chief Product Officer
In the rapidly evolving world of life sciences manufacturing, embracing innovation is key to staying ahead. Innovating in a regulated environment is often seen as risky with companies hesitant to be first. To help companies through this transition, ISPE has introduced its Pharma 4.0 initiative that provides guidance in achieving flexible, and reliable manufacturing processes. As we work with our customers and partners, we see this journey breaking down into three phases that can be used to guide implementation and deliver continuous value throughout the process.
The first crucial step in the journey to a smart factory is connecting your manufacturing assets. This involves integrating various machines, devices, and systems to create a seamless flow of data. By establishing robust connectivity, you can collect valuable operational telemetry data, which serves as the foundation for all subsequent steps.
Key Actions:
Benefits:
Once your manufacturing assets are connected and data is flowing, the next step is to monitor the real-time environment. Access to real-time data allows for better oversight of operations, enabling quick detection and correction of issues.
Key Actions:
With continuous data collection and real-time monitoring in place, the final step is to leverage predictive analytics. By analyzing historical data and identifying trends, predictive analytics can provide advanced warnings about potential issues, allowing for proactive interventions.
Key Actions:
Benefits:
"*" indicates required fields